急性肾损伤电子表型:检测、分期与亚型分类
本研究开发并验证了一种基于电子健康记录(EHR)中血清肌酐纵向变化的可计算规则算法(电子表型),用于急性肾损伤(AKI)的诊断、分期和亚型分类。该算法在哥伦比亚大学90例AKI急诊就诊和376例无AKI急诊就诊中评估测试特征,并在117,514例COVID-19感染和405,467例普通住院患者中验证。结果显示算法阳性预测值95.4%、灵敏度69.0%、特异度99.2%、总体准确率93.4%,且持续型AKI较短暂型AKI与更高死亡率相关,结果可重复。
要点
- 电子表型基于血清肌酐变化,阳性预测值95.4%、特异度99.2%,但灵敏度69.0%。
- 持续型AKI较短暂型AKI与更高30天死亡率相关,且在各疫情波次中一致。
- 算法仅依赖血肌酐,未纳入尿量或分子标志物,可能低估AKI。
核心结论
- AKI电子表型准确、可扩展,可推广至多样EHR数据集,并与死亡率有可重复关联。
研究设计与样本
- 开发基于EHR血清肌酐纵向变化的可计算规则算法,用于AKI诊断、分期和亚型分类。
- 测试特征评估:哥伦比亚大学90例AKI急诊就诊和376例无临床AKI证据的急诊就诊。
- 验证一:哥伦比亚大学医学中心117,514例COVID-19感染EHR数据。
- 验证二:波士顿贝斯以色列医学中心405,467例普通住院患者。
主要发现
- AKI电子表型阳性预测值95.4%、灵敏度69.0%、特异度99.2%、总体准确率93.4%。
- COVID-19患者中,既存CKD是AKI的独立预测因素。
- COVID-19相关AKI与死亡率呈分期依赖关联。
- 持续型AKI较短暂型AKI与更高死亡率相关,且在全部疫情波次内及波次间一致。
- 上述结果在普通住院患者数据集中可重复。
临床怎么用
- 可利用EHR肌酐数据自动检测、分期和分型AKI,辅助风险分层。
- 识别持续型AKI亚型有助于识别高死亡风险患者。
- 该工具可促进不同医疗环境下AKI研究的一致性。
局限性
- 仅依赖血清肌酐模式,无法纳入尿量或分子标志物诊断和分型AKI。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Distinguishing between transient and sustained subtypes of acute kidney injury (AKI) among hospitalized patients is valuable for clinical management and risk stratification. This study developed and validated a pragmatic electronic phenotype (e-phenotype) for the diagnosis, staging, and subtyping of AKI using electronic health record (EHR) data. STUDY DESIGN: Development of a computable rule-based algorithm to diagnose, stage, and subtype AKI using longitudinal changes of serum creatinine values recorded in an EHR. Assessment of the test characteristics of these algorithm-based diagnoses was implemented using a set of patients admitted to the emergency department (ED) with or without clinically diagnosed AKI. Validation of AKI diagnoses was implemented in 2 ways: using a set of patients hospitalized for COVID-19 and using a dataset of patients hospitalized for any cause following an ED visit. These analyses examined the associations of AKI stage and subtype with mortality. SETTING & PARTICIPANTS: Assessment of the test characteristics of the algorithm-based diagnoses: 90 ED visits for AKI and 376 visits without clinical evidence of AKI at Columbia University. Validation in the setting of COVID-19: EHR data from 117,514 instances of COVID-19 infection diagnosed at Columbia University Medical Center throughout the pandemic. Validation in the setting of general hospital admissions: 405,467 general hospital admissions at Beth Israel Medical Center in Boston, Massachusetts. TESTS COMPARED: The algorithm-based diagnosis, stage, and subtype of AKI were compared with the clinically adjudicated AKI diagnosis, stage, and subtype. OUTCOME: AKI detected, staged, and subtyped by an electronic algorithm, and 30-day mortality. RESULTS: The AKI e-phenotype had a positive predictive value of 95.4%, sensitivity of 69.0%, specificity of 99.2%, and overall accuracy of 93.4%. In COVID-19 patients, pre-existing CKD was an independent predictor of AKI. COVID-19-related AKI was associated with mortality in a stage-dependent manner. The subtype of sustained AKI was associated with higher mortality compared with transient AKI within and across all pandemic waves. These results were reproducible in the dataset of patients hospitalized for any condition. LIMITATIONS: Reliance on serum creatinine patterns alone and the inability to incorporate urine output or molecular markers to diagnose and subtype AKI. CONCLUSIONS: The AKI e-phenotype is accurate, scalable, and generalizable to diverse EHR datasets with reproducible associations with mortality. PLAIN-LANGAGE SUMMARY: Acute kidney injury (AKI) is a common and serious complication in hospitalized patients, but identifying and tracking it accurately in electronic health records is challenging. We developed an algorithm that uses patterns in kidney function test data to detect, classify, and distinguish AKI subtypes. After testing and validating the method, we applied it to 2 large hospital databases: one including patients hospitalized with COVID-19 and another including hospital admissions for any cause. Our approach reliably identified AKI and its association with poor outcomes. Patients with more severe or sustained AKI were more likely to die. This tool may help researchers study kidney injury more consistently across different health care settings.
引用
- Shang N, Xu K, Stevens JS, et al. Electronic Phenotype for Detection, Staging, and Subtyping of Acute Kidney Injury. Am J Kidney Dis. 2026. PMID: 42320578. doi:10.1053/j.ajkd.2026.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。